PARD3 and neoplasm: To confirm that the PARD3 overexpression-induced CD133+ cell population acquired tumour-initiating properties, we used an in vitro limiting dilution assay to measure the sphere-forming ability of PARD3-overexpressing CD133+ Hepa1-6 cells.